{{Rsnum
|rsid=480409
|Gene=GRM7
|Chromosome=3
|position=6968394
|Orientation=plus
|GMAF=0.3081
|Gene_s=GRM7
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 30.1 | 68.1
| HCB | 36.5 | 48.9 | 14.6
| JPT | 36.3 | 49.6 | 14.2
| YRI | 1.4 | 15.1 | 83.6
| ASW | 0.0 | 26.3 | 73.7
| CHB | 36.5 | 48.9 | 14.6
| CHD | 33.9 | 48.6 | 17.4
| GIH | 11.9 | 44.6 | 43.6
| LWK | 0.9 | 10.9 | 88.2
| MEX | 13.8 | 44.8 | 41.4
| MKK | 1.3 | 10.3 | 88.5
| TSI | 2.0 | 30.4 | 67.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=9E-6
  |OR=1.84
  |ORtxt=[1.307-2.596]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}